Skip to main content

Table 2 Laboratory findings and ventilation management of the early ventilated patients at day 3 according to in-hospital mortality

From: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

 

No

All patients (n = 1118)

Survivors (n = 685)

Non-survivors (n = 433)

p-value

Arterial blood gases

 PaO2/FiO2 ratio, mmHg

1054

180.0 [135.4–227.9]

190.0 [148.6–237.5]

158.0 [114.0–208.7]

 < 0.001

 PaO2/FiO2 ratio categories

1054

    

 PaO2/FiO2 ratio < 100 mmHg

 

98 (9.3%)

36 (5.6%)

63 (15.2%)

 < 0.001

 PaO2/FiO2 ratio ≥ 100 and < 200 mmHg

 

550 (52.2%)

317 (49.4%)

233 (56.6%)

0.023

 PaO2/FiO2 ratio ≥ 200 and < 300 mmHg

 

313 (29.7%)

232 (36.1%)

81(19.7%)

 < 0.001

 PaO2/FiO2 ratio ≥ 300 mmHg

 

91 (8.6%)

56 (8.7%)

35 (8.5%)

1.00

 pH

1082

7.39 [7.33–7.44]

7.40 [7.35–7.45]

7.37 [7.30–7.41]

 < 0.001

 PaCO2, mmHg

1090

47.0 [41.8–54.0]

46.0 [40.0–51.0]

50.3 [44.0–58.0]

 < 0.001

 Lactate, mg/dL

756

15.3 [11.7–20.1]

15.3 [11.1–19.8]

16.6 [12.6–20.7]

0.001

Laboratory findings

 Lymphocyte count, 109/L

1090

0.64 [0.41–1.00]

0.70 [0.48–1.00]

0.60 [0.38–0.90]

 < 0.001

 Neutrophil count, 109/L

472

7.58 [5.60–10.50]

7.40 [5.24–10.29]

8.10 [6.10–10.5]

0.030

 Platelet count, 109/L

1095

255.0 [189.0–325.0]

274.0 [206.5–340.0]

222.5 [168.8–293.0]

 < 0.001

 D-dimers, mg/L

754

2.31 [1.05–6.52]

1.97 [0.96–4.76]

3.27 [1.39–8.92]

 < 0.001

 Ferritin, ng/mL

345

1326 [835–2200]

1308 [790–2144]

1361 [839–2244]

0.50

 IL6, pg/mL

115

98.0 [43.1–196.6]

81.0 [44.4–191.0]

125.9 [41.7–196.9]

0.51

 CRP, mg/dL

925

10.0 [3.4–22.6]

9.3 [3.1–20.7]

10.8 [3.8–23.5]

0.09

 Bilirubin, mg/dL

957

0.75 [0.42–1.30]

0.75 [0.42–1.26]

0.76 [0.42–1.35]

0.71

 Serum creatinine, mg/dL

1101

0.92 [0.67–1.39]

0.81 [0.62–1.17]

1.10 [0.78–1.88]

 < 0.001

Ventilatory setting and pulmonary mechanics

 Tidal volume/PBW (ml/kg)

926

7.3 [6.5–8.1]

7.3 [6.5–8.1]

7.3 [6.5–8.1]

0.81

 Respiratory rate, rpm

1006

22.0 [18.0–24.0]

21.0 [18.0–24.0]

22.0 [20.0–25.0]

0.003

 PEEP, cmH2O

1051

12.0 [10.0–14.0]

12.0 [10.0–14.0]

12.0 [10.0–14.0]

0.46

 FiO2, %

1065

50.0 [40.0–60.0]

50.0 [40.0–60.0]

60.0 [50.0–70.0]

 < 0.001

 Peak inspiratory pressure, cmH2O

537

30.0 [27.0–35.0]

30.0 [27.8–34.6]

33.0 [27.0–36.0]

0.11

 End-inspiratory plateau pressure, cmH2O

413

24.0 [21.0–28.0]

24.0 [21.0–27.0]

25.0 [22.0–29.0]

0.001

 Driving pressure, cmH2Oa

401

12.0 [10.0–15.0]

12.0 [9.5–14.0]

12.2 [10.0–16.0]

0.022

 Compliance, mL/cmH2Ob

399

37.5 [28.8–48.0]

38.4 [30.0–48.3]

34.6 [25.1–46.6]

0.032

 Ventilatory ratioc

905

1.96 [1.61–2.40]

1.86 [1.53–2.24]

2.11 [1.77–2.68]

 < 0.001

 Position

967

    

 Supine

 

658 (68.0%)

451 (74.0%)

219 (58.6%)

 < 0.001

 Prone

 

285 (29.5%)

138 (23.3%)

145 (38.8%)

 < 0.001

 Other

 

24(2.5%)

16 (2.7%)

9 (2.4%)

0.84

  1. Continuous variables are expressed as median (IQR) and categorical variables as number (percentages). P-values marked in bold indicate numbers that are significant on the 95% confidence limit. CRP C-reactive protein; FiO2 fraction of inspired oxygen; PaCO2 arterial partial pressure of carbon dioxide; PaO2 partial pressure of arterial oxygen; PBW predicted body weight
  2. aDefined as plateau pressure—PEEP
  3. bDefined as tidal volume/(Plateau pressure − PEEP)
  4. cDefined as (minute ventilation × PaCO2) / (PBW × 100 × 37.5)